Clinical Trials Browser

Phase 3 × INDUSTRY × viscum album peptide × Clear all

NCT02106572 2025-07-23

TIM

Phase 3 Active not recruiting

Non-Muscle Invasive Bladder Neoplasms

NCT02191540 2014-07-23

Efficacy and Safety Study of Abnoba Viscum F 20mg in Malignant Pleural Effusion Patients

Phase 3 Completed

Pleural Effusion, Malignant